Clinical Trial Update: Multiple Sclerosis: FutureMS-2 - an Observational Cohort and Scottish Precision Medicine Study

View source ↗

Summary

FutureMS-2 is an observational cohort and precision medicine study in Scotland focusing on multiple sclerosis, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: University of Edinburgh | Conditions: Multiple Sclerosis | Status: ENROLLING_BY_INVITATION